Isabelle Casin Jacques Breuil Jean Pierre Darchis Claire Guelpa Ekkehard Collatz
10.3201/eid0911.030317
Emerg Infect Dis
2003 Nov;9(11):1455-7.
CC BY
https://pubmed.ncbi.nlm.nih.gov/14718091/
Anti-Infective Agents / therapeutic use Ciprofloxacin / therapeutic use DNA Gyrase / genetics Drug Resistance, Multiple, Bacterial / genetics Fluoroquinolones / therapeutic use Salmonella Infections / drug therapy Salmonella typhimurium / genetics
Anti-Infective Agents / therapeutic use Ciprofloxacin / therapeutic use DNA Gyrase / genetics Drug Resistance, Multiple, Bacterial / genetics Fluoroquinolones / therapeutic use Salmonella Infections / drug therapy Salmonella typhimurium / genetics Case Reports Research Support, Non-U.S. Gov't Aged DNA Gyrase / drug effects Humans Infant Male Microbial Sensitivity Tests Salmonella typhimurium / drug effects Anti-Infective Agents Fluoroquinolones Ciprofloxacin DNA Gyrase
PMC3035553
14718091
Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans
2003